Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary shares, par value of NIS 0.00001 per share
-
Shares outstanding
-
248,571,184
-
Total 13F shares
-
129,203,829
-
Share change
-
+701,674
-
Total reported value
-
$2,327,514,699
-
Put/Call ratio
-
178%
-
Price per share
-
$18.03
-
Number of holders
-
209
-
Value change
-
+$10,999,665
-
Number of buys
-
113
-
Number of sells
-
83
Institutional Holders of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) as of Q4 2025
As of 31 Dec 2025,
Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) was held by
209 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,203,829 shares.
The largest 10 holders included
True Wind Capital Management, L.P., FMR LLC, T. Rowe Price Investment Management, Inc., Voss Capital, LP, Pertento Partners LLP, Invesco Ltd., BlackRock, Inc., Clal Insurance Enterprises Holdings Ltd, Granahan Investment Management, LLC, and Phoenix Financial Ltd..
This page lists
209
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.